Qi Gao
Qi Gao, Franklin Park, NJ US
Patent application number | Description | Published |
---|---|---|
20100076191 | PROCESS FOR PREPARING TRIAZOLE SUBSTITUTED AZAINDOLEOXOACETIC PIPERAZINE DERIVATIVES AND NOVEL SALT FORMS PRODUCED THEREIN - A process is provided for preparing triazole substituted azaindoleoxoacetic piperazine derivative. Novel intermediates produced in the above process, and novel N-1 and amorphous forms of a 1,2,3-triazole substituted azaindoloxoacetic piperazine derivatives and processes for producing such novel forms are also provided. | 03-25-2010 |
20100158862 | Hepatitis C Virus Inhibitors - The present disclosure relates to compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection. | 06-24-2010 |
20100292246 | FORMULATIONS OF 1-(4-BENZOYL-PIPERAZIN-1-YL)-2-[4-METHOXY-7-(3-METHYL-[1,2,4]TRIAZOL-1-YL- )-1H-PYRROLO[2,3-C]PYRIDIN-3-YL]-ETHANE-1,2-DIONE - The instant invention provides formulations of 1-(4-benzoyl-piperazin-1-yl)-2-[4-methoxy-7-(3-methyl-[1,2,4]triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]-ethane-1,2-dione; processes for the production of such formulations; and methods of treating HIV or AIDS with such crystalline materials or such formulations. | 11-18-2010 |
20100292250 | CRYSTALLINE FORMS OF (S)-7-([1,2,4]TRIAZOLO[1,5-a]PYRIDIN-6-YL)-4-(3,4-DICHLOROPHENYL)-1,2,3,4- - TETRAHYDROISOQUINOLINE AND USE THEREOF - Novel [1,2,4]triazolo[1,5-a]pyridinyl-6-yl-substituted tetrahydroisoquinolines are described in the present invention. These compounds and crystalline forms SA1 and N-2 are used in the treatment of various neurological and physiological disorders. Methods of making these compounds and crystalline forms SA-1 and N-2 are also described in the present invention. | 11-18-2010 |
20110160220 | CRYSTALLINE FORM OF 6-[(4S)-2-METHYL-4-(2-NAPHTHYL)-1,2,3,4-TETRAHYDROISOQUINOLIN-7-YL]PYRIDA- ZIN-3-AMINE - The present disclosure generally relates to a crystalline form of 6-[(4S)-2-methyl-4-(naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine. The present disclosure also generally relates to pharmaceutical compositions comprising the crystalline form, as well of methods of using a crystalline form in the treatment of depression and other conditions and methods for obtaining such crystalline form. | 06-30-2011 |
20110268697 | Hepatitis C Virus Inhibitors - The present disclosure relates to compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection. | 11-03-2011 |
20140364441 | CRYSTALLINE FORMS OF (S)-7-([1,2,4]TRIAZOLO[1,5-a]PYRIDIN-6-YL)-4-(3,4-DICHLOROPHENYL)-1,2,3,4- -TETRAHYDROISOQUINOLINE AND USE THEREOF - Novel [1,2,4]triazolo[1,5-a]pyridinyl-6-yl-substituted tetrahydroisoquinolines are described in the present invention. These compounds and crystalline forms SA1 and N-2 are used in the treatment of various neurological and physiological disorders. Methods of making these compounds and crystalline forms SA-1 and N-2 are also described in the present invention. | 12-11-2014 |
Qi Gao, Wallingford, CT US
Patent application number | Description | Published |
---|---|---|
20090041716 | CRYSTALLINE FORM OF METHYL ((1S)-1-(((2S)-2-(5-(4'-(2-((2S)-1((2S)-2-((METHOXYCARBONYL)AMINO)-3-METH- YLBUTANOYL)-2-PYRROLIDINYL)-1H-IMIDAZOL-5-YL)-4-BIPHENYLYL)-1H-IMIDAZOL-2-- YL)-1-PYRROLIDINYL)CARBONYL)-2-METHYLPROPYL)CARBAMATE DIHYDROCHLORIDE SALT - The present disclosure generally relates to a crystalline form of methyl ((1S)-1-(((2S)-2-(5-(4′-(2-((2S)-1-((2S)-2-((methoxycarbonyl)amino)-3-methylbutanoyl)-2-pyrrolidinyl)-1 H-imidazol-5-yl)-4-biphenylyl)-1H-imidazol-2-yl)-1-pyrrolidinyl)carbonyl)-2-methylpropyl)carbamate dihydrochloride salt. The present disclosure also generally relates to a pharmaceutical composition comprising a crystalline form, as well of methods of using a crystalline form in the treatment of Hepatitis C and methods for obtaining such crystalline form. | 02-12-2009 |
Qi Gao, Shanghai CN
Patent application number | Description | Published |
---|---|---|
20080254155 | Use of Ginkgo Biloba Extract in Preparation of a Composition for Lowering Cholesterol - The use of | 10-16-2008 |
Qi Gao, Beijing CN
Patent application number | Description | Published |
---|---|---|
20080212849 | Method and Apparatus For Facial Image Acquisition and Recognition - A method and apparatus for facial image acquisition and/or recognition used for person identification. In infrared face image acquisition, near infrared (NIR) images of a face are captured by an imaging unit with the face illuminated by active NIR lights; an NIR optical filter is used in the imaging unit to minimize visible lights in environments while allowing NIR lights to pass through. NIR face images thus acquired provides good image quality for the purpose of face recognition. In face recognition, eyes are localized in NIR face image(s) quickly and accurately by detecting specular highlight reflection in each eye, whereby face is then localized. The invention effectively problems caused by environmental lights, and leads to accurate and fast face recognition under variable lighting conditions. Moreover, the methods use a non-intrusive and user-friendly way of active lighting for face image acquisition and recognition because the NIR lights are in the invisible spectrum. | 09-04-2008 |
Qi Gao, Columbus, OH US
Patent application number | Description | Published |
---|---|---|
20120030657 | METHOD AND SYSTEM FOR USING A VIRTUALIZATION SYSTEM TO IDENTIFY DEADLOCK CONDITIONS IN MULTI-THREADED PROGRAMS BY CONTROLLING SCHEDULING IN REPLAY - A method and system for determining potential deadlock conditions in a target multi-threaded software application. The target application is first run in a virtual machine and the events within the application are recorded. The recorded events are replayed and analyzed to identify potential lock acquisition conflicts occurring between threads of the application. The potential lock acquisition conflicts are identified by analyzing the order in which resource locks are obtained and pairs of resources that have respective locks obtained in different orders are analyzed. These analyzed pairs are used to define a different order of events in the target application that, when the target application is re-run with the second order of events, may trigger a deadlock condition. The target application is then re-run with the different order of events in an attempt to trigger and then identify potential deadlock situations. | 02-02-2012 |
Qi Gao, Henan CN
Patent application number | Description | Published |
---|---|---|
20150159783 | PIPE MATERIAL - The present invention discloses a pipe material including the pipe body. Spacers are set inside the pipe body. The outer wall of the spacer is in close fit with the inner wall of the pipe body. In the present invention, the spacer set inside the pipe material can well support the pipe wall and better enhance the mechanical strength and anti-bending performance of the pipe. Due to the close fit between the outer wall of the spacer and the inner wall of the pipe body, the bonding between the spacer with certain thickness and the pipe body enhances its force in any direction and improves the stress performance of the pipe body. The interaction of multiple spacers ensures the local stability of the pipe body between spacers. The interaction between the spacer and the pipe wall ultimately improves various performances of the pipe, especially its anti-bending performance. | 06-11-2015 |